These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27779306)

  • 1. [Myasthenia gravis and treatment with intravenous immunoglobulins].
    Rodriguez-Perez JA; Carballoza-Bernal A; Dorta-Contreras AJ
    Rev Neurol; 2016 Nov; 63(9):431-432. PubMed ID: 27779306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with intravenous immunoglobulin in myasthenia gravis: a review.
    Edan G; Landgraf F
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):55-6. PubMed ID: 7964855
    [No Abstract]   [Full Text] [Related]  

  • 3. IVIG in myasthenia gravis: getting enough "bang for the buck".
    Meriggioli MN
    Neurology; 2007 Mar; 68(11):803-4. PubMed ID: 17353466
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous immunoglobulin in neonatal myasthenia gravis.
    Bassan H; Spirer Z
    J Pediatr; 1999 Dec; 135(6):790. PubMed ID: 10586190
    [No Abstract]   [Full Text] [Related]  

  • 5. IVIg in the chronic management of myasthenia gravis: is it enough for your money?
    Dalakas MC
    J Neurol Sci; 2014 Mar; 338(1-2):1-2. PubMed ID: 24411405
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma exchange and intravenous immunoglobulin in autoimmune myasthenia gravis.
    Gajdos P; Chevret S; Clair B; Tranchant C; Chastang C
    Ann N Y Acad Sci; 1998 May; 841():720-6. PubMed ID: 9668320
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous immune globulin in myasthenia gravis.
    Gajdos P
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):49-51. PubMed ID: 8033435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aseptic meningitis as a complication of intravenous immunoglobulin therapy for myasthenia gravis.
    Ellis RJ; Swendson MR; Bajorek J
    Muscle Nerve; 1994 Jun; 17(6):683-4. PubMed ID: 8196714
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential predictors of response to immunomodulation in patients with myasthenia gravis.
    Li HF; Liu T; Hong Y; Zhang HL
    Muscle Nerve; 2012 Dec; 46(6):982-3; author reply 983. PubMed ID: 23225397
    [No Abstract]   [Full Text] [Related]  

  • 10. Myasthenia gravis: helping patients have better outcomes.
    Weeks BH
    Nurse Pract; 2012 Sep; 37(9):30-6; Quiz 36-7. PubMed ID: 22850535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis.
    Jensen P; Bril V
    J Clin Neuromuscul Dis; 2008 Mar; 9(3):352-5. PubMed ID: 18344718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of intravenously administered immunoglobulin in the treatment of neonatal myasthenia gravis.
    Tagher RJ; Baumann R; Desai N
    J Pediatr; 1999 Feb; 134(2):233-5. PubMed ID: 9931536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Respective indications of plasma exchange and high-dose immunoglobulins in polyradiculoneuritis and myasthenia gravis].
    Raphaël JC; Annane D; Chevret S; Chillet P; Gajdos P
    Presse Med; 1996 Oct; 25(31):1516-22. PubMed ID: 8958883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of myasthenia gravis.
    Saperstein DS; Barohn RJ
    Semin Neurol; 2004 Mar; 24(1):41-8. PubMed ID: 15229791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the evidence base for therapeutics in myasthenia gravis.
    Miller RG; Barohn RJ; Dubinsky R
    Ann Neurol; 2010 Dec; 68(6):776-7. PubMed ID: 21194147
    [No Abstract]   [Full Text] [Related]  

  • 16. Myasthenia Gravis.
    Gilhus NE
    N Engl J Med; 2016 Dec; 375(26):2570-2581. PubMed ID: 28029925
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuromuscular disease: acute treatment for myasthenia gravis.
    Gilhus NE
    Nat Rev Neurol; 2011 Mar; 7(3):132-4. PubMed ID: 21386868
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiology, symptomatology and treatment of patients with myasthenia gravis in an Australian hospital.
    Li V; Jasinarachchi M; Butler E
    Intern Med J; 2019 Dec; 49(12):1537-1540. PubMed ID: 31808263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin for preparing myasthenia gravis patients for thymectomy and other surgical procedures preventing myasthenic crisis.
    Gamez J
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):134-5. PubMed ID: 25546793
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative analysis of therapeutic options used for myasthenia gravis.
    Mandawat A; Kaminski HJ; Cutter G; Katirji B; Alshekhlee A
    Ann Neurol; 2010 Dec; 68(6):797-805. PubMed ID: 21061395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.